12 hrs ago
MediciNova to Present Data on MN-001 (tipelukast) for the Treatment...
MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today announced that it will present at the 18th International Colloquium on Lung and Airway Fibrosis to be held this September in Mont Tremblant, Quebec, Canada.
Fri Aug 29, 2014
Fibrosis treatment not ready for FDA's OK
Dear Dr. Roach: I recently was diagnosed with pulmonary fibrosis. I am an otherwise healthy 73-year-old male who underwent bypass surgery seven years ago.
Roche to buy InterMune for respiratory boost
Roche is to acquire InterMune in a deal worth $8.3 billion . The agreed takeover values the US-based company nearly two-thirds higher than its market capitalisation before market chatter about a possible takeover started a couple of weeks earlier.
Thu Aug 28, 2014
Saskatchewan to cover expensive cystic fibrosis drug
Drug-maker Vertex Pharmaceuticals reached an agreement with the provincial and territorial governments in June to enable public drug plans to cover the medication's cost.
Wed Aug 27, 2014
InterMune drug may offer big upside to Roche if aimed at liver
Roche Holding AG's planned $8 billion purchase of InterMune Inc is centered around hopes for blockbuster sales of its lung drug, but the smaller company's development pipeline may end up giving the Swiss drugmaker a far bigger bang for its buck.
Roche, InterMune a Strategic Play in Midst of Inversions
Daniel Welch, CEO of Triangle at the time, was a key player in the transaction. Soon after his gig was up at Triangle, Welch joined InterMune as president and CEO.
Tue Aug 26, 2014
iBio Enters Into $10 Million Common Stock Purchase Agreement With Aspire Capital
After the SEC declares a registration statement effective relating to the transaction, Aspire Capital has committed to purchase up to $9.5 million in additional shares of common stock over a 24 month period.
Mon Aug 25, 2014
The Washington Post
Roche to Buy InterMune for $8.3 Billion, Adding Lung Drug
Roche Holding AG, the world's largest maker of cancer drugs, is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune Inc. for $8.3 billion in cash.
Investor's Business Daily
InterMune Stock Spikes On Rare Big Biotech Buyout
InterMune stock vaulted 36% on the stock market today , a day after the biotech company agreed to be bought by Roche for $8.3 billion.
Sun Aug 24, 2014
When It Comes To Mergers/Acquisitions, Roche And Pfizer Take Different Paths
I was the president of Pfizer Global Research and Development in 2007 where I managed more than 13,000 scientists and professionals in the United States, Europe, and Asia.
The Washington Post
Roche Agrees to Buy InterMune for $8.3 Billion for Lung Drug
Roche Holding AG agreed to buy InterMune Inc. for about $8.3 billion in cash, gaining access to what may be the first drug in the U.S. for a lung disease that can be fatal within five years of diagnosis.
Fri Aug 22, 2014
Cystic fibrosis lung treatments increase longevity and quality of life
There is no known cure for cystic fibrosis. Lung treatment options focus on longevity and comfort.
Common signs and symptoms of childhood cystic fibrosis
Do you think your child may have cystic fibrosis? Are you aware of the common signs and symptoms of this disease? Cystic fibrosis is a more common childhood disease than some might think.
Thu Aug 21, 2014
New Amsterdam Sciences Continues Pact With Dr. Jacob Finkelstein , ...
New Amsterdam Sciences , an emerging bioscience company, announced today that while advancing to phase1 clinical trials it will continue its commitment for further research with renowned biochemist and research scientist Dr. Jacob Finkelstein of the University of Rochester Medical Center to advance initiatives for treatments of idiopathic pulmonary ... (more)
Wed Aug 20, 2014
This Blind Grandpa Is Running 11,000 Miles Around The U.S. To Raise Funds For Cystic Fibrosis
David Kuhn is jogging through every perimeter state in the U.S., a distance about the equivalent of 420 marathons.
Mon Aug 18, 2014
Annals of Internal Medicine
Improved Survival of Patients With Cystic Fibrosis
The full report is titled "Lifetime of Patients With Cystic Fibrosis in 2000 to 2010 and Beyond: Survival Analysis of the Cystic Fibrosis Foundation Patient Registry."
Blind Grandpa Running 11,000 Miles To Help Granddaughter
But he's averaging about 20 miles each day as he crisscrosses the country promoting a cause, in hopes of finding a cure.
New X-Ray Imaging Method for Cystic Fibrosis
Scientists at Monash University in Australia have developed an x-ray imaging system that enables researchers to see "live" how effective treatments are for cystic fibrosis .
Cystic fibrosis drug combo may be less effective than hoped
A powerful drug combo may not be as effective against cystic fibrosis as previously thought.